BOOSTRIX: payments to doctors
Payments that named BOOSTRIX as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $297K
- Providers
- 8,479
- Transactions
- 16,664
- Average per transaction
- $18
The per-transaction average — $18 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 8,479 providers the average total is $35, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| GSK | $297,182 | 100.0% |